Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.

Authors

Abdenour Nabid

Abdenour Nabid

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

Abdenour Nabid , Nathalie Carrier , Eric Vigneault , André-Guy Martin , Thu-Van Nguyen-Huynh , Jean-Paul Bahary , Peter Vavassis , Boris Bahoric , Marc-Andre Brassard , Sylvie Vass , Robert Archambault , Francois Vincent , Redouane Bettahar , Marie Duclos , Derek R Wilke , Luis Souhami

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 296)

DOI

10.1200/JCO.2024.42.4_suppl.296

Abstract #

296

Poster Bd #

M9

Abstract Disclosures

Similar Posters

First Author: Daphna Spiegel

Poster

2012 Genitourinary Cancers Symposium

Effect of zoledronic acid and biochemical relapse in treatment-naive patients with bone-metastatic prostate cancer.

Effect of zoledronic acid and biochemical relapse in treatment-naive patients with bone-metastatic prostate cancer.

First Author: Hideyasu Matsuyama